ストックスクリーナーアプリを入手
309.70
12.86%
35.29
プレマーケット:
309.70
前日終値:
$274.41
開ける：
$308.005
24時間の取引高:
2.73M
Relative Volume:
2.70
時価総額：
$22.32B
収益：
$3.07B
当期純損益:
$493.70M
株価収益率:
45.59
EPS:
6.7935
ネットキャッシュフロー:
$468.90M
1週間 パフォーマンス:
+14.78%
1か月 パフォーマンス:
+28.29%
6か月 パフォーマンス:
+0.80%
1年 パフォーマンス:
+41.95%
1日の値動き範囲:
$303.20
$320.33
1週間の範囲:
$269.98
$320.33
52週間の値動き範囲:
$199.89
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
309.70 | 19.80B | 3.07B | 493.70M | 468.90M | 6.7935 |
ISRG
Intuitive Surgical Inc
|
478.82 | 160.28B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
154.85 | 44.57B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
46.23 | 38.56B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
75.86 | 37.93B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
219.51 | 32.23B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 開始されました | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 開始されました | Barclays | Equal Weight |
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
West Pharmaceutical: Q1 Earnings Snapshot - theheraldreview.com
West Pharma lifts 2026 profit forecast on strong demand for medical equipment - 1470 & 100.3 WMBD
West Pharmaceutical Lifts Outlook After Powerful Q1 - TipRanks
BofA raises West Pharmaceutical stock price target on strong quarter By Investing.com - Investing.com Canada
A Look at West Pharmaceutical Services Inc (WST) After 12.9% Gai - GuruFocus
TD Cowen raises West Pharmaceutical stock price target on guidance By Investing.com - Investing.com Australia
West Pharma sees plastics, elastomer demand surge with GLP-1 growth - Plastics News
[10-Q] WEST PHARMACEUTICAL SERVICES INC Quarterly Earnings Report - Stock Titan
WST Stock Climbs As Dublin Expansion Targets GLP‑1 Drug Wave - StocksToTrade
WST Stock Climbs As Dublin Expansion Targets GLP-1 Drug Boom - timothysykes.com
West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1 - Benzinga
West Pharmaceutical Services, Inc. Raises Earnings Guidance for the Full Year 2026 - marketscreener.com
West Pharmaceutical Services Q1 2026 Earnings Call Transcript - MarketBeat
Evercore ISI raises West Pharmaceutical price target on strong results By Investing.com - Investing.com Canada
West Pharmaceutical Services, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
West Pharmaceutical Stock Is Soaring After Earnings. It’s a Sneaky GLP-1 Play. - Barron's
WST Stock Jumps on Q1 Earnings & Sales Beat, EPS View Up on HVP Growth - TradingView
West Pharmaceutical Services Reports Strong Q1 2026 Results Driven by Double-Digit Organic Net Sales Growth - Minichart
West Pharmaceutical (WST) jumps on Q1 beat and raised 2026 outlook - Quiver Quantitative
West Pharmaceutical Services Stock Climbs As Dublin Expansion Targets Obesity Drug Boom - timothysykes.com
West Pharma jumps as packaging components drive strong Q1 beat - MSN
West Pharmaceutical Q1 2026 slides: 47% EPS surge on biologics boom - Investing.com
West Pharmaceutical Services Crushes Q1 2026 Profit Estimates by 26.0% - AlphaStreet
West Pharmaceutical Q1 2026 slides: 47% EPS surge on biologics boom By Investing.com - Investing.com South Africa
West Pharma Sees FY EPS $8.15-EPS $8.50 >WST - Moomoo
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
Compared to Estimates, West Pharmaceutical (WST) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: West Pharmaceutical Services Q1 2026 beats expectations - Investing.com Canada
West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Second Quarter 2026 - marketscreener.com
West Pharma stock jumps after strong Q1 beat (WST:NYSE) - Seeking Alpha
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Is West Pharmaceutical (WST) 23.2% Undervalued After Q1 2026 Bea - GuruFocus
West Pharmaceutical Raises 2026 Outlook After Strong Quarter - TipRanks
West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Form 8-K WEST PHARMACEUTICAL SERV For: Apr 23 - StreetInsider
West (NYSE: WST) posts 21% Q1 sales growth and raises 2026 guidance - Stock Titan
Why West Pharmaceutical Services Stock Is Dropping Now - TipRanks
WEST PHARMACEUTICAL SVSC ($WST) Releases Q1 2026 Earnings - Quiver Quantitative
(WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.40$8.75, vs. FactSet Est of $8.01 - marketscreener.com
(WST) West Pharmaceutical Expects 2026 Revenue Range $3.3B$3.35B, vs. FactSet Est of $3.25B - marketscreener.com
(WST) West Pharmaceutical Services, Inc. Expects Q2 Revenue Range $830.0M$850.0M - marketscreener.com
(WST) West Pharmaceutical Services, Inc. Expects Q2 Adjusted EPS Range $2.05$2.12 - marketscreener.com
Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q1 Revenue $844.9M, vs. FactSet Est of $780.3M - marketscreener.com
Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q1 Adjusted EPS $2.13 per Share, vs. FactSet Est of $1.68 - marketscreener.com
West Pharmaceutical Services (NYSE:WST) Surprises With Strong Q1 CY2026, Stock Soars - Yahoo Finance
West Reports First-Quarter 2026 Results - Carroll County Mirror-Democrat
West Pharmaceutical Q1 2026 earnings preview - MSN
West Pharmaceutical earnings loom as GLP-1 exposure in focus By Investing.com - Investing.com Australia
West Pharmaceutical earnings loom as GLP-1 exposure in focus - Investing.com
Earnings To Watch: West Pharmaceutical Services (WST) Reports Q1 Results Tomorrow - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
2.74%
0.55%
大文字化:
|
ボリューム (24 時間):